Illuminating a Potential Culprit in Melanoma Treatment Resistance
Researchers may have uncovered the mechanisms behind the development of targeted therapy resistance in melanoma.
Researchers may have uncovered the mechanisms behind the development of targeted therapy resistance in melanoma.
Noted physician-scientist studies molecular underpinnings of cardiovascular disease
Should cancer patients avoid sugar? Senior research dietitian Erma Levy explains what you should know about sugar consumption during cancer treatment.
PHILADELPHIA (April 26, 2024) — Thirteen Fox Chase Cancer Center nurses have been honored as 2024 Top Nurses by Main Line Today in its May…
Researchers have discovered a significant function of the Id3 protein in the persistence and operational capabilities of tissue-infiltrating alloreactive T cells, offering insights that could…
Those who have been previously treated for KRAS G12C–mutated advanced NSCLC may benefit from treatment with glecirasib.
Podcasts | The Hematologist | American Society of Hematology Podcasts The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights…
Exagamglogene autotemcel gave most patients with beta-thalassemia transfusion independence and drastically reduced the number of vaso-occlusive crises in those with sickle cell disease in a…
Summary: . We are building the world’s first Virtual Child–a computer model of normal and cancerous human development at the level of each individual cell.…
Introduction During a comprehensive presentation by Dr. Catherine Coombs at UC Irvine, insights into the unique challenges and opportunities of using CAR T-c
An abstract is unavailable.